Patients deserve affordable access to the best healthcare possible. That’s why Pfizer invests in research and development: to produce groundbreaking treatments, like the COVID-19 vaccine, that improve people’s lives. It’s this investment in innovation that enables our scientists to make dramatic strides in healthcare. Their work advances life-changing therapies for the millions of patients we serve.
Pfizer provided treatments for 2.4 million cancer patients and 64 million patients with cardiovascular disease in the second quarter of 2020.
To help even more patients access the medications they depend on, we need smart public policies that support both access and innovation. Americans deserve healthcare solutions that:
- Increase affordable access to breakthrough treatments.
- Support the development of lower-cost alternatives by increasing access to biosimilars.
- Deliver meaningful healthcare savings directly to patients through rebate reform that cuts out the middlemen.
- Promote market competition and protect innovation by rejecting foreign price controls on prescription drugs.
As the new administration and Congress take office, Americans want to hear solutions for protecting innovation while improving patient access to life-saving treatments!